Inventor

Liliane Unger

Inventor

Ludwigshafen, DE

Overview

1988–2018

Patent span

Human necessities

Primary field (CPC A)

Patents· 125 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds40%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%

A61KPreparations for medical, dental or toiletry purposes16%

C07CAcyclic or carbocyclic compounds2%

C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds0%

F16JPistons0%

PatentTitleYear

10,160,744Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT2018 9,657,002'Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseases'2017 9,487,505'Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them'2016 9,434,713'5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases'2016 9,422,264'Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases'2016 9,403,796'Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses'2016 9,388,141'Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor'2016 9,388,148'Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor'2016 9,376,396'Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor'2016 9,273,036'Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases'2016 9,238,642'Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses'2016 9,023,854'5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases'2015 9,006,276'Substituted oxindole derivatives, medicaments containing said derivatives and use thereof'2015 8,969,552'Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2015 8,859,557'Substituted oxindole derivatives and their use as vasopressin receptor ligands'2014 8,815,868'Substituted oxindole derivatives and their use as vasopressin receptor ligands'2014 8,791,148'Substituted benzimidazolone derivatives, medicaments comprising them and their use'2014 8,772,313'Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor'2014 8,710,059'N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor'2014 8,703,774'Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases'2014 8,703,775'Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses'2014 8,691,815'Substituted oxindole derivatives, drugs containing said derivatives and the use thereof'2014 8,642,642'Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor'2014 8,629,148'Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses'2014 8,580,842'Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them'2013 8,546,401'5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases'2013 8,507,469'Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2013 8,497,273'Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor'2013 8,492,540'1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,486,984'Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,486,931'Substituted oxindole compounds'2013 8,476,275'N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor'2013 8,470,810'Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,440,694'Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor'2013 8,431,567'Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands'2013 8,383,641'Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2013 8,362,010'Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2013 8,349,843'Carboxylic acid derivatives, their preparation and use'2013 8,350,055'Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them'2013 8,343,959'N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2013 8,338,590'Substituted oxindole derivatives and medicaments containing the same'2012 8,293,913'Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor'2012 8,242,102'Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2012 8,232,426'Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2012 8,207,160'Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor'2012 8,202,868'4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2012 8,202,870'Substituted oxindole derivatives, medicaments containing the latter and use thereof'2012 8,183,237'Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2012 8,129,389'Substituted oxindole derivatives, medicaments containing the latter and use thereof'2012 8,119,676'Substituted benzimidazolone derivatives, medicaments comprising them and their use'2012 8,101,754'Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2012 8,076,326'N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2011 8,044,079'Substituted oxindole derivatives, medicaments containing said derivatives and use thereof'2011 8,008,488'Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands'2011 RE042477'Carboxylic acid derivatives, their preparation and use'2011 RE042462'Carboxylic acid derivatives, their preparation and use'2011 7,951,807'Substituted oxindol derivatives and medicaments containing the same'2011 7,902,379'Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them'2011 7,863,445'Carboxylic acid derivatives, their preparation and use'2011 7,851,463'Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2010 7,834,048'Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2010 7,803,834'Substituted oxindole derivatives, drugs containing said derivatives and the use thereof'2010 7,790,727'Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2010 7,759,397'6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor'2010 7,601,730'Carboxylic acid derivatives, their preparation and use'2009 7,582,647'Carboxylic acid derivatives, their preparation and use'2009 7,465,744'Triazole compounds and the therapeutic use thereof'2008 7,320,979'N-[(piperazinyl)hetaryl]arylsulfonamide compounds'2008 7,119,097'Carboxylic acid derivatives, their preparation and their use'2006 7,109,205'Carboxylic acid derivatives, their preparation and use'2006 6,686,369'-hydrdroxylic acid derivatives, their production and use'2004 6,670,367'Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists'2003 6,610,691'Carboxylic acid derivatives, their production and use'2003 6,602,867'Triazole compounds with dopamine-D3-receptor affinity'2003 6,600,043'Carboxylic acid derivatives, their preparation and use'2003 6,583,166'Triazole compounds with dopamine-D3-receptor affinity'2003 6,579,892'Triazole compounds with dopamine-D3-receptor affinity'2003 6,509,341'Carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists'2003 6,472,392'Triazole compounds and the use thereof as dopamine-D3 -ligands'2002 6,458,821'N-substituted azabicycloheptane derivatives, production and use thereof'2002 6,448,248'Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists'2002 6,444,674'Substituted pyrimidine compounds and the use thereof'2002 6,440,975'Amino acid derivatives, the preparation and use thereof as endothelin antagonists'2002 6,403,593'Triazole compounds and the use thereof'2002 6,387,912'Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia'2002 6,358,983'Heterocyclically substituted -hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists'2002 6,352,981'Substituted AZA- and diazacycloheptane and -cyclooctane'2002 6,342,604'Substitute pyrimidine compounds and the use thereof'2002 6,300,354'N-substituted azabicycloheptane derivatives, production and use thereof'2001 6,214,822'Substituted aza and diazacycloheptane and cyclooctane compounds and their use'2001 6,197,958'Carboxylic acid derivatives, their preparation and use'2001 6,124,294'Triazole compounds and the use thereof'2000 6,103,732'Carboxylic acid derivatives, their production and use'2000 6,090,807'Use of heterocyclic compounds'2000 6,028,073'N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics'2000 6,004,988'Carboxylic acid derivatives, their preparation and their use'1999 5,969,134'Carboxylic acid derivatives, their preparation and use'1999 5,958,923'Use of thiazole and thiadiazole compounds'1999 5,932,730'Carboxylic acid derivatives, their preparation and use'1999 5,908,844'N-substituted azabicycloalkane derivatives, their preparation and use'1999 5,840,722'Use of carboxylic acid derivatives as drugs'1998 5,753,690'N-substituted azobicycloheptane derivatives, the preparation and use thereof'1998 5,703,091'N-substituted azabicycloalkane derivatives, their preparation and use'1997 5,693,637'Bicycle derivatives, their preparation and use'1997 5,616,705'N-substituted azabicycloheptane derivatives, their preparation and use'1997 5,521,209'N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof'1996 5,512,584'1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof'1996 5,424,312'Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, the preparation and use thereof'1995 5,424,330'Benzofurancarboxamides having basic substituents, the preparation thereof, and therapeutic agents containing them'1995 5,418,235'Aminoalkyl-substituted 5-mercaptothiazoles, the preparation and use thereof'1995 5,401,743'Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof'1995 5,401,762'Aminoalkyl-substituted thiazolin-2-ones, the preparation and use thereof'1995 5,356,901'Benzofurancarboxamides having basic substituents, the preparation thereof, and therapeutic agents containing them'1994 5,342,839'2-hydroxy-3-phenoxy-propyl-substituted piperazines, their preparation and use'1994 5,342,853'Method of using nor-verapamil and nor-gallopamil as anti-arteriosclerotics'1994 5,264,452'Benzofurancarboxamides and therapeutic agents'1993 5,151,437'Benzofurancarboxamides having basic substituents and therapeutic agents containing the same'1992 5,071,864'Aminoalkyl-substituted 2-aminothiazoles and therapeutic agents containing them'1991 4,968,717'Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances'1990 4,945,114'Therapeutic agents containing enantiomers of propafenone'1990 4,940,780'Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds'1990 4,914,125'(S)-emopamil for the treatment of migraine'1990 4,885,278'5-substituted 10-cyanomethylenethieno(3,4-B)benzazepines'1989 4,866,057'4-substituted 10-cyanomethylenepyrrolo[4,3-e]-benzazepines'1989 4,745,111'Anti-anxiety, anti-agitation, and anti-sleepless states 4-substituted 10-cyanomethylenethieno-[4,3-e]benzoazepine derivatives, compositions, and methods of use therefor'1988

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1988–2003Patents assigned to BASF AG (40)· patent assignee history

1988–2018Based in Ludwigshafen, DE· patent location history

2003–2014Patents assigned to ABBOTT GMBH & CO KG (48)· patent assignee history

2011–2015Patents assigned to UNGER LILIANE (41)· patent assignee history

2011–2015Patents assigned to HAUPT ANDREAS (22)· patent assignee history

2013–2018Patents assigned to ABBVIE DEUTSCHLAND (23)· patent assignee history

2016–2017Based in Wiesbaden, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ABBOTT GMBH & CO KG	48	2003–2014
UNGER LILIANEself	41	2011–2015
BASF AG	40	1988–2003
ABBVIE DEUTSCHLAND	23	2013–2018
HAUPT ANDREAS	22	2011–2015

Locations

Location	Patents	Span
Ludwigshafen, DE	122	1988–2018
Wiesbaden, DE	3	2016–2017